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q None of the authors have a financial or proprietary interest in the products, methods, or materials presented in this paper.Abdulaziz AlHadlaq a; Salem AlMalki b,⇑; Sami AlShahwan aAbstractWe report an extremely rare presentation of late-onset endophthalmitis in a young adult patient with an unexposed Ahmed tube
implant. The implant was inserted 11 years prior to presentation. There was no history of trauma or any obvious exposure on
clinical examination and the tube plate was filled with purulent material. After aqueous and vitreous tap, the patient underwent
intracameral, intravitreal subconjunctival antibiotic injections and was started on systemic antibiotics with good response.
Endophthalmitis associated with tube drainage device can present as late as 11 years and even without an unexposed tube.
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Glaucoma drainage implants (GDIs) are often used for
controlling intraocular pressure (IOP) in patients with refrac-
tory glaucoma. The intraoperative and postoperative compli-
cations of GDIs include, infection, hypotony, hyphema,
cataract, corneal decompensation and failure to control IOP.1
Endophthalmitis is a rare, vision threatening complication
of any intraocular surgical procedure. Typically endoph-
thalmitis occurs within days or weeks postoperatively.1
Late-onset endophthalmitis after GDI has been reported as
late as 2 years postoperatively.2 Late-onset cases of
GDI-related endophthalmitis present with an exposed tube
or endophthalmitis occurred after needling or repositioning.3
The incidence of GDI related endophthalmitis in adults in
Saudi Arabia is 0.9%.1 To the best of our knowledge, sponta-
neous late-onset endophthalmitis past 2 years postopera-
tively and without exposure of a GDI is extremely rare. Wepresent a case of late onset endophthalmitis of an unexposed
GDI more than a decade after the procedure.
Case report
A 28-year-old female presented for routine follow-up to
the glaucoma department complaining of blurry vision, red-
ness and pain in her left eye for the preceding 10 days. The
patient was already using lubricant eye drops. The patient
had undergone uneventful trans-scleral cyclophotocoagula-
tion for high IOP 1 month prior to presentation. At that time
the patient was prescribed predforte 1% (Allergan Inc.,
Dublin, Republic of Ireland) on a tapering dose over 1 month
and ofloxacin 0.3% drops four times daily for 2 weeks. The
patient was medically healthy but was a documented case
of congenital glaucoma. The patient had undergone multiple
glaucoma surgeries bilaterally. Surgical history of the right
eye included a failed Ahmed glaucoma valve implante:
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implant five years previously. The left eye had undergone 2
failed trabeculectomies with antimetabolites 15 years previ-
ously followed by uncomplicated Ahmed glaucoma valve
implantation inferonasally 12 years prior to presentation.
On ophthalmic examination her visual acuity was 20/200
and 20/60 in right and left eyes respectively. Intraocular pres-
sures were 16 mmHg and 18 mmHg in right and left eyes
respectively. Slit lamp examination of the right eye indicated
a clear cornea with deep, quiet anterior chamber and a well-
positioned tube with an immature cataract, flat retina and
normal lids. The conjunctiva of the left eye was injected espe-
cially inferiorly, the cornea was clear, and there were 3+ cells
in the anterior chamber, hypopyon surrounding the tube and
a hazy view of the vitreous. The left eye had no lid swelling,
no tenderness and no exposure from the tube or any leak
(Fig. 1). There was minimal vitreous haze and no retino-
choroidal layer thickening on B-scan ultrasonography of the
left eye.
The patient was diagnosed with early stage endophthalmi-
tis of the left eye and aqueous and vitreous taps were per-
formed. The left eye underwent intracameral, intravitreal
and subconjunctival injections of ceftazidime and van-
comycin. The patient was prescribed oral ciprofloxacin
400 mg four times a day for 2 weeks in addition to topical
steroid four times daily for one week and then tapered to
three times a day then twice a day and after that once daily
for one week each then it was stopped. Topical antibiotics
were prescribed including fortified ceftazidime 50 mg/ml
and topical vancomycin 25 mg/ml hourly both for five days
and then were changed to topical ofloxacin 4 times a day.
Computerized tomography (CT) was performed to rule out
paranasal sinus pathology or orbital disease that could
explain the source of the unusual inflammation. CT was nor-
mal and the aqueous and vitreous samples were negative
for any pathogen. The left eye improved over the following
days and the patient was discharged after the condition
was well-controlled one week after admission. At follow-up,
1 week later, the visual acuity in the left eye was 20/40 with
a quiet conjunctiva with no anterior chamber reaction. During
examination, we applied external pressure to depress the
tube and noted discharge of purulent material from the tube
into the anterior chamber (Fig. 2). Hence, we considered the
tube the source of infection, most likely from the plate. TheFigure 1. Slit lamp examination of the left eye with conjunctival injection
and hypopyon surrounding the tube at initial presentation.tube was examined externally with fluorescein and was
negative for leak or exposure. Surgery was performed to
completely remove the tube, plate and implant and send
them for microbial and cytology analysis. A replacement tube
was not implanted. We also requested additional testing for
atypical organisms such as mycobacteria. Gross examination
of the tube and plate after removal indicated the purulent
discharge filled the plate. The microbiology results were
negative for bacterial growth and fungal growth. Cytology
analysis indicated an acute inflammatory response.Discussion
Endophthalmitis is one of the most serious complications
following intraocular surgery. In the setting of glaucoma sur-
gery, the risk of endophthalmitis extends well beyond the
immediate postoperative period. It is critical that both
patients and physicians recognize the signs and symptoms
of infection, with the understanding that these may present
even years after surgery. For example, a retrospective study
of Medicare claims data reported the cumulative incidence
of endophthalmitis in the first year after glaucoma drainage
device (GDD) placement was 0.4%.4 In the Trabeculectomy-
versus-Tube study, endophthalmitis developed in 1 of 107
eyes in the GDI group and 5 of 105 in the trabeculectomy
group over 5 years.2 Hence endophthalmitis presenting years
after surgery should be considered in patients with a history
of GDI surgery. The majority of GDI-related endophthalmitis
is commonly late onset (6 weeks postoperatively or later).1,2,5
In a case series of GDI-associated endophthalmitis, tube
exposure was present in all cases.3 However, our case was
not associated with obvious tube exposure or conjunctival
erosion. Transcleral cyclophotocoagulation (CPC) was per-
formed 1 month prior to presentation and some may ques-
tion whether this was the inciting event to endophthalmitis.
However CPC is a non-invasive procedure that has not been
reported to be associated with endophthalmitis. Hence, as
the Ahmed glaucoma tube preceded CPC, the most likely
explanation is that CPC caused a microerosion, resulting in
an invasion of a pathogenic organism from the conjunctival
cul-de-sac to the subconjunctival space toward the tube plate
and subsequent colonization. Haemophilus influenzae andFigure 2. At first follow-up (1 week), vision was 20/40 with a quiet eye.
However, during examination purulent material around the tube was
noted and, discharge of purulent material from the tube into the anterior
chamber was noted when external pressure was applied to the tube.
Late onset endophthalmitis 127Streptococcus pneumoniae were isolated in children with
Ahmed glaucoma valve-related endophthalmitis in Saudi
Arabia.1 In adults, endophthalmitis related to Ahmed
glaucoma valve included Streptococcus species and
Pseudomonas aeruginosa.1 Al-Torbak and colleagues have
documented that the types of microbes causing
GDI-related endophthalmitis are similar in Saudi Arabia and
the western hemisphere. Treatment of GDI-related infectious
endophthalmitis can range from evisceration to intravitreal
antibiotics. Previous studies have recommended shunt
removal because it may serve as a reservoir for the pathogen.
We elected to remove the Ahmed glaucoma valve because
we felt it was the source of the endophthalmitis. However,
outcomes for removal of GDI in endophthalmitis remain
ambiguous.1,2
The culture and the stain results were negative for bacte-
rial and fungal microbes. Cytology analysis indicated an acute
inflammatory response. We found that the eye improved with
frequent instillation of topical steroids. Taken together, these
three observations could indicate sterile endophthalmitis as
an alternate possibility. Sterile endophthalmitis has been
reported in patients with GDI.6 Sterile endophthalmitis is an
acute intraocular inflammation that either resolves without
antibiotics or is culture-proven negative.7 However even in
culture-proven negative cases, empirical treatment with
antibiotics covering potential microbes may be judicious.8
We believe that this case was either an infection due to an
unusual organism that could not be isolated using the usual
culture media and the staining techniques or a case of sterile
immune response against the tube plate. Whether CPC was
the major inciting event and/or trigger remains unknown as
there are no similar cases reported in the literature (to the
best of knowledge). In conclusion, endophthalmitis inglaucoma drainage device is rare. However, it can present
without conjunctival erosion or tube exposure and can pre-
sent as late as 11 years postoperatively.
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